The 17-member independent Vaccines and Related Biological Products Advisory Committee will meet Thursday to review and discuss data from Pfizer and German startup BioNTech on their vaccine, then vote on whether the FDA should authorize it.
The 17-member independent Vaccines and Related Biological Products Advisory Committee will meet Thursday to review and discuss data from Pfizer and German startup BioNTech on their vaccine, then vote on whether the FDA should authorize it.